Get the latest ARNA - Arena Pharmaceuticals Inc. stock market performance data and financial news.
Get the latest ARNA - Arena Pharmaceuticals Inc. together with stock market performance data and financial news.
Get the latest ARNA - Arena Pharmaceuticals Inc. stock market performance data and financial news.
Read Jim Cramer's take on Arena Pharmaceuticals Inc. (ARNA) and get his latest thoughts on the company?s performance and outlook
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Patients taking lorcaserin lost a placebo-adjusted 3.1% of their body weight after one year. But that stat falls short of the 5% placebo-adjusted weight loss benchmark that many doctors believe is clinically meaningful.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10600270/1/arena-drug-aids-weight-loss-a-little.html
Arena Pharmaceuticals reported phase III trial data for obesity drug lorcaserin that did not hit all FDA standards.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10479159/1/arena-defends-obesity-drug-as-stock-plunges.html
Drug company Arena Pharmaceuticals is under pressure to produce stellar results from a phase III study of its obesity drug later this month.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10475839/1/obesity-drug-arenas-heavy-burden.html
A quick and dirty guide to the expected regulatory news from the FDA through June 2010.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10645419/1/biotech-calendar-upcoming-fda-dates.html
Safety of Abbott's Meridia may heighten concerns for all weight-loss drugs. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10630804/1/fda-issues-new-obesity-drug-heart-warning-biobuzz.html
Connect with TheStreet